FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/099917 [Registered on: 29/12/2025] Trial Registered Prospectively
Last Modified On: 24/12/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Kshara Pratisarana Karma]  
Study Design  Other 
Public Title of Study   SNUHI KSHARA PRATISARANA KARMA IN THE MANAGEMENT OF APEENASA - CHRONIC HYPERTROPHIC RHINITIS AN OPEN LABEL DOUBLE ARM CONTROL CLINICAL TRIAL 
Scientific Title of Study   A RANDOMISED OPEN LABEL DOUBLE ARM CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF SNUHI KSHARA PRATISARANA KARMA IN THE MANAGEMENT OF APEENASA - CHRONIC HYPERTROPHIC RHINITIS 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sanjai S Menon  
Designation  PG Scholar 
Affiliation  SDM INSTITUTE OF AYURVEDA AND HOSPITAL 
Address  Department of Shalakya Tantra SDM Institute of Ayurveda Hospital Anchepalya Kumbalgodu Post Bengaluru Karnataka
Department of Shalakya Tantra Anchepalya, Kumbalgodu Post Bengaluru, Karnataka ,Pin: 560074
Bangalore
KARNATAKA
560074
India 
Phone  8848700242  
Fax    
Email  drsanjaimenon@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr Mamatha K V  
Designation  Professor and HOD 
Affiliation  SDM Institute of Ayurveda Hospital 
Address  Department of Shalakya Tantra OPD 16 SDM Institute of Ayurveda Hospital Anchepalya Kumbalgodu Post Bengaluru Karnataka
Department of Shalakya Tantra OPD 16
Bangalore
KARNATAKA
560074
India 
Phone  9845393236  
Fax    
Email  mamatha.sova@gmail.com  
 
Details of Contact Person
Public Query
 
Name  ProfDr Mamatha K V  
Designation  Professor and HOD 
Affiliation  SDM Institute of Ayurveda Hospital 
Address  Department of Shalakya Tantra OPD 16 SDM Institute of Ayurveda Hospital Anchepalya Kumbalgodu Post Bengaluru Karnataka
Department of Shalakya Tantra OPD 16
Bangalore
KARNATAKA
560074
India 
Phone  9845393236  
Fax    
Email  mamatha.sova@gmail.com  
 
Source of Monetary or Material Support  
SDM Institute of Ayurveda and Hospital  
 
Primary Sponsor  
Name  Sanjai S Menon 
Address  SDMIAH Anchepalya Kumbalgodu Post Bengaluru 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Sanjai S Menon  SDM Institute of Ayurveda and Hospital   Department of Shalakya Tantra OPD numbers 10,1116,22 SDMIAH Anchepalya, Kumbalgode Post BANGALORE
Bangalore
KARNATAKA 
8848700242

drsanjaimenon@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee SDMIAH   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J310||Chronic rhinitis. Ayurveda Condition: APINASAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Snuhi kshara, Reference: Susrutha Samhitha, Route: Nasal, Dosage Form: Kshara , Dose: 0.5(mg), Frequency: sos, Bhaishajya Kal: Abhakta, Duration: 1 Days, anupAna/sahapAna: No, Additional Information: Kshara Pratisarana karma
2Comparator ArmDrugClassical(1) Medicine Name: Apamarga Kshara , Reference: Susrutha Samhitha , Route: Nasal, Dosage Form: Kshara , Dose: 0.5(mg), Frequency: sos, Bhaishajya Kal: Abhakta, Duration: 1 Days, anupAna/sahapAna: No, Additional Information: Kshara Pratisarana Karma
 
Inclusion Criteria  
Age From  20.00 Day(s)
Age To  50.00 Day(s)
Gender  Both 
Details  Patients presenting with lakshanas of Apeenasa Chronic hypertrophic rhinitis
Age 20-50 years
 
 
ExclusionCriteria 
Details  Malignancy
Nasal Papilloma Nasal polyp
Congenital anomalies of Nose and Sinus
Subjects with gross Deviated Nasal Septum More than 150
Subjects with history of systemic illness that interferes the course of treatment 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduction in the size of Hypertrophic turbinates after kshara pratisarana karma from the base score  On first assessment day zero and second assessment day eight of the study 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction in symptoms of apeenasa from before & after treatment.
Changes in Nasal obstruction symptom evaluation (NOSE) scale from base score
Standardization of the instrument to measure hypertrophied turbinate
 
On first assessment day zero & second assessment day eight of the study 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   18/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This study is a randomized open label double arm controlled clinical trial designed to evaluate the efficacy of Snuhi Kshara Pratisarana Karma in the management of Apeenasa Chronic Hypertrophic Rhinitis in comparison with Apamarga Kshara Pratisarana which is taken as the control. Chronic hypertrophic rhinitis is a common cause of persistent nasal obstruction due to irreversible hypertrophy of the inferior turbinates, and in Ayurveda it closely correlates with Apeenasa characterized by features such as nasanaha nasa srava shirashula gurgura swasam and gandha ajnana. Classical Ayurvedic texts particularly Charaka and Sushruta Samhitas describe Kshara Pratisarana as an appropriate line of management in conditions involving adhimamsa hypertrophy especially in anatomically delicate areas like the nasal cavity.

The study includes 40 patients aged 20 to 50 years diagnosed with Apeenasa Chronic hypertrophic rhinitis who are randomly allocated into two groups of 20 each. Group A receives Apamarga Kshara Pratisarana while Group B receives Snuhi Kshara Pratisarana with 0.5 to 0.7 g of Kshara applied over the hypertrophied inferior turbinates until pakwa jambu phala varna is attained, followed by neutralization and post procedure care. The duration of the intervention is 8 days with assessments conducted before and after treatment. Outcome measures include subjective improvement in symptoms such as nasal obstruction headache abnormal respiratory sounds and olfactory disturbance as well as objective assessment of turbinate size using anterior rhinoscopy photographic documentation a modified Castroviejo caliper and the Nasal Obstruction Symptom Evaluation scale. Statistical analysis will be performed using appropriate parametric and non-parametric tests. The study aims to determine whether Snuhi Kshara Pratisarana is superior or comparable to Apamarga Kshara in reducing turbinate hypertrophy and alleviating symptoms thereby providing an effective minimally invasive Ayurvedic alternative to conventional medical and surgical management of chronic hypertrophic rhinitis.


 
Close